Gout trials in China

In China 15 Also abroad 51

13 of 15 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of Efficacy and Safety of IBI3011 in Subjects With Acute Gouty Arthritis
Where
Jing’an
Age
18 years to 75 years
People
132
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT07842497
Phase 2Taking people
A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis
Where
Bengbu, Binzhou, Changchun, Chengdu, Chongqing, Ganzhou, Guilin, Huzhou, Jiangmen, Jining, Langfang, Linfen, Linyi, Luoyang, Mianyang, Nanning, Pingxiang, Shanghai, Shijiazhuang, Taiyuan, Wuhan, Wuxi, Xiangtan, Yangzhou, Yibin, Zaozhuang, Zhengzhou, Zhongshan, Zhuzhou
Age
18 years and over
People
170
Run by
TJ Biopharma Co., Ltd.
See details and how to joinNCT07453004
Phase 2Taking people
Clinical Study of HRS-2129 for Acute Gouty Arthritis
Where
Guangzhou, Nanjing
Age
18 years and over
People
90
Run by
Shandong Suncadia Medicine Co., Ltd.
See details and how to joinNCT07706777
Phase 1Taking people
A Study of IN026 in Participants With Refractory Gout
Where
Wuhan
Age
18 years to 75 years
People
16
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07587684
Phase 1Enrolling by invitation
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral F-02-2-Na Tablets in Adult Subjects
Where
Guangzhou
Age
18 years to 45 years
People
69
Run by
Guangdong Hengqin Novagains Biopharmaceutical Co., Ltd.
See details and how to joinNCT07324434
No phaseTaking people
Tart Cherry Citrate Effervescent Tablet for Urate-Lowering Therapy in Participants With Asymptomatic Hyperuricemia
Where
Xiamen
Age
18 years to 65 years
People
196
Run by
Beijing Zhecheng Biotechnology Co., Ltd.
See details and how to joinNCT07613138
No phaseNot yet taking people in China
24-Week Recurrence Rate of Gout Following Firsekibart Treatment
Where
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
Age
18 years to 75 years
People
264
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07625514
No phaseNot yet taking people in China
Efficacy and Safety of Scheduled Versus As-Needed Firsekibart Administration for the Prevention of Gout Recurrence: A Multicenter, Open-Label, Randomized Controlled Trial
Where
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
Age
18 years to 75 years
People
118
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07616531
Phase 2Taking people
The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary Gout and Hyperuricemia
Where
Shanghai
Age
18 years to 75 years
People
340
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07362355
Phase 1Taking people
A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
Where
Bengbu
Age
18 years to 70 years
People
36
Run by
Shanghai Institute Of Biological Products
See details and how to joinNCT06298071
No phaseNot yet taking people in China
Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCT
Where
Shenyang
Age
18 years to 70 years
People
120
Run by
XueMei Guo
See details and how to joinNCT07326839
Phase 1Taking people
Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and Hyperuricemia
Where
Shanghai
Age
18 years to 65 years
People
60
Run by
Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT06629376
Phase 4Taking people
Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release Tablets
Where
Shanghai
Age
18 years to 70 years
People
312
Run by
Huashan Hospital
See details and how to joinNCT06966635